Camson Bio Technologies Ltd
Camson Bio Technologies is engaged in the Business of Agricultural Biotech Products.
- Market Cap ₹ 9.93 Cr.
- Current Price ₹ 3.31
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 14.9
- Dividend Yield 0.00 %
- ROCE -19.2 %
- ROE -39.3 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.22 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -49.4% over past five years.
- Company has a low return on equity of -25.8% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 512 days.
- Working capital days have increased from 329 days to 731 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
33 | 39 | 65 | 85 | 95 | 117 | 140 | 157 | 24 | 9 | 18 | 5 | 5 | |
24 | 29 | 47 | 62 | 73 | 89 | 116 | 141 | 39 | 23 | 18 | 21 | 26 | |
Operating Profit | 9 | 10 | 18 | 23 | 22 | 28 | 25 | 16 | -14 | -13 | 0 | -16 | -21 |
OPM % | 27% | 25% | 27% | 26% | 23% | 24% | 18% | 10% | -59% | -141% | 0% | -350% | -438% |
0 | 0 | 0 | 1 | 0 | 0 | -3 | 6 | 1 | 4 | 1 | 3 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 4 | 5 | 7 | 5 | 1 | -0 |
Depreciation | 1 | 1 | 2 | 1 | 2 | 3 | 5 | 13 | 22 | 7 | 7 | 7 | 7 |
Profit before tax | 8 | 8 | 16 | 22 | 20 | 23 | 13 | 5 | -40 | -23 | -11 | -21 | -25 |
Tax % | 3% | 5% | 7% | 2% | -1% | 0% | -5% | 39% | -5% | -1% | 0% | 3% | |
8 | 8 | 15 | 22 | 21 | 23 | 13 | 3 | -38 | -23 | -11 | -22 | -25 | |
EPS in Rs | 7.95 | 5.92 | 9.41 | 12.16 | 11.45 | 12.71 | 5.27 | 1.03 | -12.61 | -7.68 | -3.74 | -7.30 | -8.40 |
Dividend Payout % | 0% | 17% | 11% | 8% | 9% | 8% | 19% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -19% |
5 Years: | -49% |
3 Years: | -42% |
TTM: | -48% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 12% |
TTM: | -46% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -7% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | -14% |
3 Years: | -26% |
Last Year: | -39% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 14 | 16 | 18 | 18 | 18 | 25 | 30 | 30 | 30 | 30 | 30 |
Reserves | 18 | 26 | 59 | 89 | 107 | 143 | 202 | 234 | 74 | 47 | 37 | 15 |
2 | 1 | 1 | 1 | 12 | 41 | 40 | 37 | 47 | 46 | 49 | 50 | |
2 | 6 | 9 | 23 | 15 | 14 | 16 | 25 | 21 | 24 | 26 | 28 | |
Total Liabilities | 32 | 47 | 85 | 131 | 153 | 217 | 282 | 325 | 172 | 147 | 142 | 122 |
13 | 18 | 29 | 27 | 35 | 78 | 110 | 139 | 106 | 95 | 88 | 81 | |
CWIP | 0 | 0 | 6 | 11 | 22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 0 | 6 | 3 | 3 | 3 |
19 | 28 | 50 | 89 | 96 | 138 | 173 | 187 | 60 | 49 | 50 | 37 | |
Total Assets | 32 | 47 | 85 | 131 | 153 | 217 | 282 | 325 | 172 | 147 | 142 | 122 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | 1 | 10 | -2 | 10 | -13 | -15 | 14 | -10 | 5 | 2 | 0 | |
-6 | -7 | -19 | -21 | -20 | -25 | -36 | -43 | 5 | 3 | 1 | -0 | |
2 | 5 | 22 | 10 | 9 | 39 | 51 | 28 | 4 | -7 | -3 | -0 | |
Net Cash Flow | -2 | -0 | 14 | -13 | -1 | 1 | 0 | -1 | -0 | -0 | 0 | -0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 54 | 69 | 66 | 182 | 180 | 199 | 218 | 342 | 249 | 145 | 101 | 512 |
Inventory Days | 421 | 481 | 564 | 734 | 543 | 386 | 218 | 121 | 697 | 1,766 | 1,847 | 628 |
Days Payable | 33 | 31 | 10 | 237 | 102 | 27 | 19 | 51 | 517 | 1,105 | 378 | 185 |
Cash Conversion Cycle | 442 | 519 | 619 | 679 | 621 | 559 | 417 | 412 | 428 | 806 | 1,570 | 955 |
Working Capital Days | 165 | 201 | 149 | 275 | 293 | 306 | 293 | 373 | 120 | -192 | 448 | 731 |
ROCE % | 33% | 24% | 28% | 24% | 17% | 15% | 9% | 3% | -15% | -12% | -5% | -19% |
Documents
Announcements
- Initiation of Liquidation Process & Appointment of Liquidator 13 Jan 2021
-
Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)
28 Feb 2020 - Corporate Insolvency Resolution Process of Camson Bio Technologies Limited (the Corporate Debtor) commenced by the order of National Company Law Tribunal, Bengaluru Bench, (NCLT) on …
- Intimation of Corporate Insolvency Resolution Process (CIRP) against Camson Bio Technologies Limited and appointment of Resolution Professional 28 Feb 2020
-
Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)
12 Nov 2019 - An Interim Resolution Professional (IRP) has been appointed till date but no one has approached us to take charge.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
16 Oct 2019 - Mr. Virendra Kumar Singh (DIN: 07226146) and Mr. Manoj Srivastava (DIN: 00513960), Independent Directors of the Company has resigned from their position w.e.f. 16th October, …